Abstract 6511: Androgen receptor (AR) genomic alterations and clinical outcome with prostate-specific membrane antigen (PSMA)-targeted radionuclide therapyMichael Sun, Scott T. Tagawa, Muhammad Junaid Niaz et al.|Cancer Research|2020Cited by 3
Supplementary Figures 1-4 from <sup>18</sup>F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast CancersNicolaos Palaskas, Ingo K. Mellinghoff, Joseph R. Osborne et al.|Unknown|2023Cited by 0
Supplementary Figure 3 from <sup>18</sup>F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast CancersNicolaos Palaskas, Ingo K. Mellinghoff, Steven M. Larson et al.|Unknown|2023Cited by 0
Supplementary Figure 4 from <sup>18</sup>F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast CancersNicolaos Palaskas, Ingo K. Mellinghoff, Steven M. Larson et al.|Unknown|2023Cited by 0